Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
about
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical applicationNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data.Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a reviewMagnetic resonance relaxation properties of superparamagnetic particles.Hepatic tumor imaging using iron oxide MRI: comparison with computed tomography, clinical impact, and cost analysis.Safety of approved MR contrast media for intravenous injection.Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.Safety of MR liver specific contrast media.In vivo clearance and toxicity of monodisperse iron oxide nanocrystals.Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions.Characterization of focal hepatic lesions with SPIO-enhanced MRI.Perturbational profiling of nanomaterial biologic activityBiliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.Surgical therapy for colorectal metastases to the liver.Feasibility of Leadless Cardiac Pacing Using Injectable Magnetic MicroparticlesTargeted polymeric therapeutic nanoparticles: design, development and clinical translationContrast agents for hepatic MRI.Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3TDetection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.Engineered nanoparticles for biomolecular imaging.Chemical design of biocompatible iron oxide nanoparticles for medical applications.Magnetic resonance relaxation induced by superparamagnetic particles used as contrast agents in magnetic resonance imaging: a theoretical review.Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor.Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer.Liver cancer imaging: role of CT, MRI, US and PET.Synthesis of europium-doped VSOP, customized enhancer solution and improved microscopy fluorescence methodology for unambiguous histological detection.Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance.[Radiological diagnosis of primary hepatic malignancy].Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.Time-to-echo optimization for spin echo magnetic resonance imaging of liver metastasis using superparamagnetic iron oxide particles.
P2860
Q24613744-6D39C7D1-A39E-4356-B901-BE11700512E9Q30387307-F2EACA91-6BEC-4528-9A92-4B978043E496Q30559573-7EAFB442-EF99-4305-8FDF-34111916B808Q30576477-36EBBDA0-8467-481D-B028-FC2C93834EB5Q31934521-AC38A2CC-FDA1-490A-B75A-48EFCDADD29DQ33503551-FA50805E-F032-42DC-940F-7FA96BF4F2FBQ33521948-45A9AD1C-9FAA-4868-9C44-048617ADB1F8Q33773028-D654352E-5323-4035-9A3A-8367BCD26A79Q33994713-2CDAE49B-6408-418D-A109-02541E3BC8E6Q34562932-E266440F-C0AF-4D69-AE3B-E91FDBF3EF53Q35056708-CD18B941-713B-496F-BE75-89457BFB84B7Q35207733-84802D5D-2839-40C7-BF63-18A703104332Q35897368-7ECBF7DD-5FF3-415F-91E3-01F057BAC8B9Q35997318-AF446608-17BC-4B93-B898-E9366E1DD552Q36105117-7C1C77EA-0A2F-4BD2-A731-442B9BDECD5DQ36179721-DCC73398-512B-4F46-AFCC-FBDCE4E3B844Q36309136-50756261-93DD-4F0F-AC1A-8F1774D987F6Q36677215-C32890C7-091D-478C-8D11-7D66E146FDE0Q36789118-5B64F121-D132-4D85-BAF2-411EB4273764Q36832322-15D914E4-1204-49CD-BC04-A15A6BF353A4Q36926987-423CBF4D-6CCA-4AFF-99B6-008E3F228162Q36934007-7BB89BBC-6391-46E4-904D-DF935ED0AC07Q36963721-FA056D44-9CD4-447E-BB52-C15D7C5778D5Q37133482-542F46CE-F8F9-453D-A35F-ACF771824736Q37231625-974F5E8D-146C-4FF8-B5B5-BA2A2C91C358Q37270092-A015F2AE-91B8-4192-8232-60DACD9C4F83Q37276760-3BB798C6-F268-4A4E-B4C3-D94212C3D530Q37602017-97545A9C-A076-4A9F-919F-F919CF422714Q37832406-7FE06CDE-4C0C-49E6-B293-8C093B52928EQ37895953-6D7F2DA8-13DD-4E36-A592-66C661712533Q38066814-7A2DE26F-9425-4C2C-9A0E-FD55C5758B78Q38842822-6DEBD18D-E36F-40CC-81BC-836C64ACCD48Q40379207-A647630A-1114-4597-9FFD-C39E5EB1A127Q41352771-F97D3081-4DF7-483C-AD06-409E4FCC6687Q41872601-01893F5D-2B87-453A-8C95-113063712163Q42374097-A8361027-0304-4C57-9A96-6192D51FC64DQ43728476-C4B86DB0-D701-439D-A220-BDF180A5A95BQ43954477-7237F8C9-B6B5-40A4-8B33-251F68A46567Q45076926-5CB40445-FF03-41E8-92FE-1FAEA5E06B6AQ46950233-07AE1730-490C-42D9-9C39-B7EDFFF507DA
P2860
Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@en
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@nl
type
label
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@en
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@nl
prefLabel
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@en
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@nl
P2093
P1433
P1476
Hepatic MR imaging with ferumo ...... tion of focal hepatic lesions.
@en
P2093
A E Stillman
L R Muroff
M A Nissenbaum
P C Freeny
S E Seltzer
P304
P356
10.1148/RADIOLOGY.196.2.7617864
P407
P577
1995-08-01T00:00:00Z